Microsoft beat on top and bottom lines but Azure growth slowed.Technologyread more
Trump said the USS Boxer destroyed Iran's drone in the Strait of Hormuz on Thursday in a "defensive action."Politicsread more
Stocks erased earlier losses, but the rise was kept in check as Wall Street digested a mixed batch of corporate earnings results.US Marketsread more
President Trump said he's looking at the JEDI Contract that will be awarded to Microsoft or Amazon.Technologyread more
Business advocacy organizations sharply criticized the House of Representatives for passing a bill to raise the minimum wage to $15, saying it would be a costly job killer.Politicsread more
heart devices@ (Adds details on the recall, background)
July 1 (Reuters) - The U.S. Food and Drug Administration said on Monday three deaths had been reported related to Edwards Lifesciences Corp's recall of some of its heart devices.
The agency said the company's voluntary recall of its IntraClude intra-aortic occlusion device in May has now been classified by the FDA as Class I.
Class I recall is the strictest form of recall issued by the FDA, where use of faulty devices may cause serious injury or death.
The FDA said that recall affects more than 750 devices in the United States.
The recall was due to a risk of balloon rupture during use of the devices, the FDA said https://www.fda.gov/medical-devices/medical-device-recalls/edwards-lifesciences- r e c a l l s - i n t r a c l u d e - i n t r a - a o r t i c - o c c l u s i o n - d e v i c e - d u e - r i s k - b a l l o o n - r u p t u r e , adding the company received 22 complaints related to the device.
The IntraClude intra-aortic occlusion device is used in patients undergoing cardiopulmonary bypass, where the device temporarily takes over the functions of the heart and lungs during surgery. (Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Shailesh Kuber)